A nucleoprotein (NP) preparation purified from the chorioallantoic membrane of chicken eggs infected with fowl plague virus (A/FPV/Rostock/34, H7N1) yielded, in addition to the commonly known 56K protein, a 42K component that could not be detected in virus particles. After testing with a series of NP-specific monoclonal antibodies it was found that some reacted with both proteins and others were bound only by the 56K protein. Among both types of NP-specific monoclonal antibodies only a limited number were bound to infected murine cells. Some antibodies bound to cells infected with a given subtype failed to react with the surface of cells infected with a different subtype. Binding was demonstrated by cellular ELISA, radioimmunoassay and immunofluorescence. The results indicate that only restricted antigenic domains of the native NP and perhaps NP fragments are exposed at the surface of infected murine cells. Additionally, the purified NP preparation was used to immunize mice in order to determine the protective capacity of cellassociated NP. In parallel, and as a relevant control, mice were immunized with a vaccinia virus recombinant containing the gene for NP prior to challenge with infectious virus. High levels of monospecific antibodies and a cytotoxic T cell activity was found in mice immunized with purified NP or infected with the vaccinia recombinant after secondary restimulation in vitro. After treatment with specific antibodies the cytotoxic cells were shown to be classical CD8 + cytotoxic T lymphocytes.-Despite the elicitation of a humoral and a cellular immune response by the forms of NP employed mice were not protected from influenza virus infection.
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Introduction
The common antigenicity of the nucleoprotein (NP) of influenza type A viruses is not only defined by typespecific anti-NP antibodies, but NP is also recognized by cross-reactive cytotoxic T cells (CTL) (Braciale, 1977; Effros et al., 1977; Zweerink et al., 1977; Townsend & Skehel, 1984; McMichael et al., 1986) . This type-specific reactivity does not necessarily affect all the strains belonging to the A type; Townsend & Skehel (1982) and Fleischer et al. (1985) found CTL clones that are fully cross-reactive, but also others that recognized only a limited number of subtypes. The analysis of the surface of infected cells with NP-specific monoclonal antibodies (MAbs) described in the present paper reveals a similar picture for NP recognized by antibodies; there is a limited exposure of NP-specific antigenic determinants in addition to a uniform type-specific pattern.
The use of recombinant viruses or of cells transfected with the cloned influenza virus RNA segment 5, which encodes NP, as target cells verified the recognition of NP by cross-reactive CTL. Furthermore, by using truncated NP genes and synthetic peptides certain amino acid sequences of the NP were defined as antigenic determinants recognized by crossreactive CTL (Townsend et al., 1985 (Townsend et al., , 1986 . We report here the isolation of native NP from cells and discuss its potential significance for recognition by CTL. We also evaluate whether NP-specific T cell reactivity is relevant in helping the host to overcome an influenza infection, as has been postulated recently employing NP obtained from virus cores (Wraith et al., 1987) .
In a series of experiments we found that purified NP was unable to protect mice. Similarly, immunization of mice with vaccinia virus carrying the NP-coding segment 5 of influenza virus failed to induce protective immunity.
Preparation of MAbs. BALB/c mice were immunized with purified NP mixed with an equal volume of aluminium hydroxide (Serva) intraperitoneally (i.p.). Four to 8 weeks after primary immunization fusions were carried out 4 days after the booster injection, according to standard procedures (K6hler & Milstein, 1975) , using either FO or Ag 8.653 myeloma cells (Fazekas de St Groth & Scheidegger, 1980; Kearney et al., 1979) . Growing hybridomas were screened for NPspecific antibodies by a solid-phase ELISA and positive cells were cloned by limiting dilution. Mouse MAbs were purified by affinity chromatography and were adjusted after dialysis against phosphatebuffered saline (PBS) to a protein concentration of 1 mg/ml.
ELISA. Hybridoma supernatants and purified MAbs were tested for their reactivity in a solid-phase ELISA, using purified NP antigen as a coating agent. Samples were incubated for 1 h at 37 °C in coated roundbottom microtitre plates and binding was detected with biotinylated anti-mouse Ig and streptavidin-biotinylated horseradish peroxidase complex (Amersham).
For the demonstration of NP at the surface of infected cells MAbs were tested in parallel on cells infected with different influenza A (FPV; A/PR/8/34, H1N1 ; A/Asia/57, H2N2) and influenza C viruses. Briefly, 1 × 105 to 2 × 105 cells were added to flat-bottom microtitre plates that had been precoated with poly-t-lysine (Mr 300 000; Sigma) and centrifuged for 5 rain at 400g. Plates were then washed twice and saturated for 30min with 0.1~ bovine serum albumin (BSA) and 0.01 ~ sodium azide in PBS. Fifty ~tl of antibody at an appropriate dilution in PBS supplemented with 5~ foetal calf serum was added to the wells for 1 h at room temperature (RT). The cells were washed, incubated with 50 ~tl biotinylated anti-mouse Ig (Amersham) for 1 h at RT, washed again and incubated with 50 ~tl alkaline phosphataseavidin conjugate (Bio-Yeda) for 30 rain at RT. 4-Nitrophenylphosphate (1 mg/ml) in diethanolamine buffer containing 0.5 M-levamisole (in order to block endogenous alkaline phosphatase activity) was used as the substrate. Finally, the reaction was evaluated in an ELISA reader at a wavelength of 405 rim. In all experiments viability of cells was determined by trypan blue dye exclusion and viability always ranged between 95 and 100~ before addition of the substrate.
Further serological procedures for the demonstration of NP at the cell surface. 1ZSl.labelled straptavidin was used in a radioimmunoassay that was set up similarly to the ELISA technique. The reaction was graded as positive if the absolute counts exceeded by twofold the background value, which was defined by the reaction of antibodies with uninfected cells. Positive values always corresponded to more than three to five standard deviations above background.
For immunofluorescence Mc57G cells (mouse fibroblasts) infected with influenza A or C viruses were kept in PBS containing 0.1 ~ BSA and 0-01 ~ sodium azide throughout the testing. As well as MAbs, sera from mice immunized with influenza virus strains FPV, PR8, Asia and influenza C and monospecific anti-NP mouse sera were examined. Uninfected ceils served as negative controls.
Immunoblot analysis. Following SDS PAGE the proteins were transferred onto polyvinylidenefluoride membrane strips (Millipore) for 90 min at 0.8 mA/cm 2. Thereafter the membranes were saturated with 10 ~ horse serum and 2 ~ BSA in PBS/0.05 ~ Tween 20 for 30 min at RT. After several washings with PBS/Tween MAbs or antisera were added at a dilution of 1 : 100 in PBS/Tween for 1 h at RT. Bound antibodies were visualized with streptavidin-labelled horseradish peroxidase (Amersham) and 4-chloro-l-naphthol as substrate.
Mice. Female and male mice from the following strains were either bred at the Institut fiir Virologic, Giessen or at the Institut fiir Zuchthygiene, Zfirich: NMRI, CBA/J (H-2k), C57BL/6 (H-2b), DBA/2 (H-2 d) and ICR (H-2q). Mice were used at an age of 8 to 12 weeks.
Influenza wild-type virus. In these studies the following viruses were used: influenza viruses A/FPV/Rostock/34 (H7N1), A/PR/8/34 (H1N1), A/Asia/57 (H2N2), A/HK/1/68 and influenza C. For in vivo studies vesicular stomatitis virus (VSV) Indiana was also used. Mice were infected intravenously (i.v.) with influenza A viruses PR/8/34 and HK/1/68. For intranasal (i.n.) challenge mouse-adapted PR/8/34 and HK/1/68, which were lethal at high doses for all tested mouse strains, were used. They were a gift from Dr O. Hailer, Institut fiir Immunologie und Virologie, Universit~it Zfirich.
Influenza-vaccinia virus recombinants.
Vaccinia recombinant virus expressing the external or internal influenza virus gene products of PR/8/34 (H1N1) were used for i.v. immunization of mice. vP208 (expressing haemagglutinin) was generated as described by Panicali et al. (1983) . For the generation of vP261 a 1560 bp EcoRI fragment containing the gene coding for the influenza NP was isolated from pAPR501 (P. Palese, Mount Sinai Medical Center) and cloned downstream from the promoter in the plasmid pSD640PP, generating pSD640PPNP, which was recombined into VTK-79 vaccinia virus by marker rescue (Panicali & Paoletti, 1982) . As a control a vaccinia virus recombinant expressing the NP of VSV Indiana (INDN 
Influenza NP does not confer protection 1171
Immunization of mice with CAM-NP. Mice were immunized with 100 ~tg of CAM-NP in PBS mixed with an equal volume of aluminium hydroxide. Three weeks later the animals were challenged by i.n. instillation of 30 lal of homogenized lung tissue of mice infected with Asia virus after one or three passages in mice. From each group the surviving animals were killed, their antibody titres were determined, and hepatization of their lungs was recorded. One half of the lung was homogenized for virus titration and the other half fixed for histological examination.
Priming with vaccinia virus recombinants and challenging of mice. C57BL/6, DBA/2 and ICR mice were immunized i.v. with 5 x 106 of either the wild-type influenza A viruses or the PR/8/34--vaccinia recombinants. Fourteen or 40 days later the mice were challenged i.n. with a dose that was 100-fold higher than the LD50 of the employed influenza A viruses.
Induction of effector lymphocytes and cytotoxicity test.
Both assays were performed essentially as described (Stitz et al., 1985) . For secondary in vitro restimulation of effector lymphocytes 5 x 106 responder (R) spleen cells from C57BL/6 (H-2 b ) or CBA/J (H-2 k) mice, which had been immunized i.p. 4 to 12 weeks eadier with 50 to 100 H A U in allantoic fluid, or with 50 to 100 txg CAM-NP in aluminium hydroxide, were used per 24-well Costar plate; syngeneic irradiated spleen cells or macrophages acutely infected with virus or incubated with CAM-NP were used as stimulators (S) at R : S ratios of 1 : 1 or 30 : 1, respectively. For secondary restimulation in vivo either approximately 200 H A U of FPV in aUantoic fluid, or 100 lag CAM-NP in adjuvant, were given i.p. and spleen cells were harvested 6 days later.
In some experiments effector cells were treated with MAbs YTS 191.1 (anti-CD4; Cobbold et al., 1984) or YTS 169.4 (anti-CD8; Cobbold et al., 1984) . The MAbs were a kind gift of Dr H. Waldmann. For treatment, 5 × 106 washed cells were incubated with MAbs (1 : 100 dilution) for 30 min on ice, washed twice and then incubated with 1 ml of a 1:15 dilution of Low-Tox rabbit complement (Cedarlane Laboratories) for 30 min at 37 °C. The cells were treated twice by the same procedure.
Target cells for the cytotoxicity assay included mouse fibroblasts L 929 (H-2 k) and Mc57G (H-2 b) and peritoneal macrophages from C57BL/6 (H-2b). Both cell types were either infected with a high m.o.i. (approx. 200 HAU) of influenza virus per 106 cells, or incubated with the purified CAM-NP preparation for 1 h at 37 °C. Thereafter cells were washed and labelled for another hour with 51Cr. CTL activity was tested in a conventional cytotoxicity assay in round-bottom microtitre plates with 1 x 104 per well during 5 h at the indicated effector :target ratios.
Standard volumes (1 ml) containing standard numbers (5 x 106) of effector cells generated in vitro were treated with antibody and complement in vitro and were resuspended in a standard volume before being tested at various dilutions.
Results

Preparation of CAM-NP
The CAM extracts were repeatedly passed through the immunosorbent columns until diminished elution peaks indicated exhaustive absorption of NP. The subsequent ion-exchange chromatography that had previously been employed (Fleischer et al., 1985) concentrated the NP from relatively large elution volumes. Pre-running the focusing gel for 5 h furnished an alkaline environment at the cathodic side of the gel plate, where the NP solution could be applied without precipitation. NP precipitates did form in the acidic region at the end of the run (Fig. 1 ), but were not soluble in distilled water. Ampholines and contaminating material that stayed in solution could thus be rinsed from the gel by H20. The antigen could be recovered from the gel in a slightly alkaline buffer containing urea. Fig. 1 shows that the maximal amount of NP accumulated at pH 4.8. Since the bands containing the focused NP were not straight across the plate, peak values varied up to pH 5.2 in different runs; the isoelectric point of NP can therefore be defined within this pH range of 4-8 to 5-2.
Analysis of NP in immunoblots using MAbs
When this protein peak from the electrofocusing gel was examined by SDS-PAGE two bands appeared, a major one at the usual position of the NP (56K) and another one with an Mr of 42K (Fig. 2) . The relative proportions of the two bands varied somewhat from one preparation to the other. Immunoblots carried out with convalescent serum from a chicken infected with the alien subtype virus Victoria (H3N2) or a mouse infected with PR8 (H1N1) or NP-specific rabbit serum, showed that the 42K fraction had NP-specific antigenicity. A more detailed analysis was reached with MAbs prepared from mice that had been immunized with CAM-NP. Some MAbs reacted with both bands (Fig. 3a , lane 2), analogous to NP-specific polyclonal rabbit sera, and others were exclusively bound by the 56K component (Fig. 3a, lane 1) . However, no reaction exclusively directed against the smaller 42K component was found.
When purified virus was tested by SDS-PAGE and immunoblots only the 56K position was stained in all !ases, including the antibodies that reacted with both bands of the CAM-NP (Fig. 3b) .
Demonstration of NP antigen on the surface of infected cells
A panel of 13 MAbs were selected for further analysis because of their unequivocal and constant reactions in a solid-phase ELISA. When these MAbs were tested on plates coated with purifed virus particles of the virus strains FPV, PR8 and Asia, all MAbs reacted to variable degrees with all virus preparations (Fig. 4) . The reactivity of MAbs was tested 12 h after the infection of primary chick embryo fibroblasts and Mc57G mouse fibroblasts when the maximal expression of NP was found. other of these cells, as exemplified in Fig. 5 . No preference could be seen for any of these reaction patterns when antibodies were used that reacted with both the 42K fragment or the 56K molecule.
These results could be confirmed by radioimmunoassays and the reactions could also be visualized by immunofluorescence (data not shown). An irregular distribution of fluorescent patches could be observed on the surface of infected cells, whereas no reaction was found in the cases of the MAbs in Table 1 Group A.
Lack of protection of mice by CAM-NP
When NMRI mice that had been immunized i.p. with purified NP in adjuvant were challenged with 6 x 104 p.f.u./animal, survival periods were identical in the immunized and the nonimmunized mice (Table 2) . Challenge with 6 x 103 p.f.u./mouse resulted in the same death rates in either group. No difference in the course of the disease could be noted. Virus reached maximal titres of about 107 p.f.u./g lung tissue between days 3 and 5 post-infection. The extent of hepatization and histopathological alterations in the lungs was comparable in immunized and control groups. Table 2 also shows that immunization with the same amount of NP that had been released from particles and purified by isoelectric focusing failed to induce a protective effect, as did NP isolated from CAM.
Anti-NP antibody titres in serum samples obtained immediately before challenge ranged between 1:2560 and 1 : 10240 in all immunized mice as determined by solid-phase ELISA, and showed monospecificity in Western blots (data not shown). The challenge infection stimulated a secondary immune response in surviving mice. 
Protection of mice by priming with vaccmia-influenza virus recombinants
C57BL/6 (H-2b), DBA/2 (H-2 d) and ICR (H-2 q) mice were primed 14 or 40 days before lethal i.n. challenge with PR8 with either a wild-type influenza A virus (PR8 or HK), or with recombinant vaccinia virus expressing the haemagglutinin (vP208) or the NP (vP261) of PR8 (Fig. 6 ). Mice immunized with vP261 had antibody titres in the ELISA of 1:1260 to 1:5120 that exhibited monospecificity for NP, as shown by Western blot analyses (data not shown). I.n. challenge with a mouseadapted PR8 strain produced lethal pneumonitis within 6 to 12 days. The time course of mortality in C57BL/6 and ICR mice is shown in Fig. 7(a, b) where vaccination was carried out 14 days before challenge. The prodromal period before death lasted 8 to 10 days for untreated C57BL/6 and DBA/2 mice (data not shown); thereafter all mice died within a period of 4 days. In ICR mice a more scattered type of kinetics of mortality was observed, with a range of prodromal periods from 2 to 10 days after i.n. challenge. As shown in Fig. 7(a, b) a clear protection could only be demonstrated for mice primed with the wild type virus PR8, or the vaccinia virus recombinant expressing the haemagglutinin of PR8. No significant number of mice survived when immunized with the vaccinia virus recombinant expressing the NP of PRS. The survival rate of these mice was in the range of the control mice primed with the vaccinia recombinant expressing the NP of VSV. Partial protection was achieved only in C57BL/6 mice by immunizing with the heterologous serotype HK. To evaluate the duration of the protection conferred by the wild-type influenza virus or by the vaccinia virus recombinants, DBA/2 mice were primed at two time points, i.e. 14 or 40 days before lethal i.n. challenge. The same protection pattern was observed for both time intervals (Table 3) . 
Induction of CTL by CAM-NP
In order to establish whether the isolated cell-associated NP was able to prime for specific CTL, mice were immunized with virus or CAM-NP. Four weeks after immunization restimulation was either carried out in vitro (Table 4) or mice were restimulated in vivo (Table 5) with virus or CAM-NP. Both methods revealed comparable results. After immunization with CAM-NP and restimulation with virus significant lysis of virus-infected or NP-treated target cells was observed (Tables 4 and 5 , groups 3). The same was true when mice were immunized with virus and restimulated with the purified NP preparation (Table 5 , group 2).
After elimination of CD8 ÷ T cells from effector cell populations the cytotoxic activity was completely abolished, whereas treatment of effector cells with anti-CD4 MAbs did not result in a reduction of cytotoxic activity on target cells infected either with the homologous virus (Asia) or a heterologous virus (FPV), with respect to the priming virus (Asia). The same was true for effector cells from mice primed with the vaccinia recombinant virus containing the NP gene. For secondary restimulation in vitro either live virus or the purified NP (CAM-NP) was used (Table 6 ).
Discussion
NP purified from FPV-infected CAM by immunoaffinity chromatography and electrofocusing contained not only the 56K protein normally found in virus particles, but also a smaller component, which lacked a peptide of about 14K. It is evident that at least one antigenic determinant must be located on this missing piece, since we found MAbs that did not react with the 42K protein, but readily bound the full-length 56K NP. The fact that all MAbs reacting with the 42K protein were also bound by the larger NP species indicates that the 42K fragment is derived from the 56K protein by proteolytic cleavage at a specific site. The slightly smaller NP with an Mr of 53K, which has been described in lysates of cells infected with some influenza virus strains (Zhirnov & Bukrinskaya, 1981; Wraith & Askonas, 1985) , was not seen in our preparations. NP-specific antigenic determinants could be detected with these MAbs by ELISA or radioimmunoassay at the cell surface. When their distribution on the cell membrane was visualized by immunofluorescence patches were observed, similar to those described previously by Virelizier et al. (1977) . A number of antibodies, whose NP specificity had been ascertained by solid-phase ELISA and immunoblots, were not bound to the surface of the infected host cell. This could mean that certain domains of the NP are closely associated with the membrane, or they are inserted in the bilayer where they are inaccessible to antibodies. Furthermore, Fig. 5 and Table 1 show that the appearance of some other (additional) epitopes is not uniform throughout all type A viruses, but varies according to the subtype used for infection. Designation of domains located at overt or cryptic sites must await further analysis. One could imagine that a panel of MAbs could define a pattern of exposed epitopes unique for each subtype. Since all MAbs used in this study for the analysis of the surface of infected cells are uniformly reactive with all subtypes in a solid-phase ELISA, the surface pattern listed in Table 1 cannot depend on varying antigenicities (Davenport et al., 1960; Schild et al., 1975; van Wyke et al., 1980) ; rather, they must be due to variations in the expression of NP or fragments thereof on the cell membrane. The varying exposure of different NP domains at the cell surface may perhaps correspond to patterns of reactivity of NP-specific CTL clones (Townsend & Skehel, 1982; Fleischer et al., 1985) .
Despite the exposure of at least some epitopes at the surface of infected cells immunization of mice with NP did not have any protective effect. This was not only true when a lethal dose of a mouse-adapted virus strain was used (Table 2) , but protection was also absent when immunized mice were challenged with a less adapted virus strain that produced clinical signs but was only rarely lethal (data not shown). Clinical manifestations, survival rates, virus titres in lung tissues, gross lesions of the lungs and histopathological findings were virtually identical in immunized and control groups. Since very high titres of T cell-dependent antibodies were produced, a potent immune response must have taken place.
In view of the potent anti-NP antibody response and the NP-associated determinants exposed at the cell surface in a form recognizable by these antibodies, one could have anticipated the functioning of an antibodydependent cytotoxic mechanism possibly influencing the course of an influenza virus infection. However, none of the immunization protocols and challenge experiments revealed any evidence for such a mechanism being effective under the experimental conditions employed.
Similarly, no protection could be observed after a challenge infection in mice that had been immunized with a vaccinia virus recombinant containing the gene for the NP of PR8 (vP261). In contrast, and illustrating the efficiency of an immunization with a recombinant virus, mice immunized with a recombinant expressing the haemagglutinin of PR8 (vP208) were fully protected. These findings are in agreement with Andrew & Coupar (1988) who were also unable to demonstrate protection of mice that had been infected with a vaccinia-NP recombinant virus and were challenged 4 days later. These results differ from other studies (Wraith & Askonas, 1985; Wraith et al., 1987) , where immunization of mice with NP had a substantial protective effect, which was attributed to cross-reacting CTL. These authors used a NP preparation that was extracted from bromelain-treated virus by detergent without further purification. Although cross-reactive CTL were shown to be primed by this NP preparation, the experiments do not establish whether T cells, or possibly induced anti-NP antibodies, might have contributed to protection. We were also able to demonstrate reactivity of CTL after secondary restimulation of mice that had been immunized with CAM-NP; nevertheless we did not find any evidence for protection. By treatment of effector cell populations with specific antibodies directed against different T cell subsets plus complement we were able to demonstrate clearly the action of classical CD8 ÷ CTL. This was true for the recognition of exogenous antigen as well as for the newly synthesized cytoplasmic NP introduced into cells by the vaccinia virus recombinant. Furthermore, we were unable to detect major histocompatibility complex (MHC) class II antigens on the surface of mouse fibroblast cell lines L 929 and Mc57G used in these experiments, despite the use of various protocols for the induction of this MHC antigen (our own unpublished observation). At the same time the latter results exclude the action of recently described influenza virus-specific Lyt-2 ÷ MHC class II-restricted T cells (Morrison et al., 1985; HiDe & Hinshaw, 1989) .
It is possible that the sometimes rather low activity of CTL and/or the mode of antigen presentation and processing determines the lack of any protective effect of CAM-NP. However, the latter alone is not sufficient to explain the finding, since active synthesis of NP that had been introduced intracellularly by infection with a vaccinia virus recombinant for optimal antigen presentation was not capable of inducing protective immunity, despite its capacity to elicit a T cell response.
The experiments presented suggest that immunization with cell-derived NP, either using a highly purified form or using vaccinia recombinant virus, may not readily lead to protection. This finding is in contrast to successful immunization of mice with a vaccinia recombinant virus containing NP of lymphocytic choriomeningitis virus (Hany et al., 1989) . These discrepancies might have several explanations. Firstly, the induced NP-specific T cell memory is very short-lived and therefore was not detected after 14 days. The challenge with infectious virus 4 days after primary immunization with a vaccinia recombinant expressing NP, as performed by Andrew & Coupar (1988) , might have been too early to show protective effects. Secondly, the spread of i.n. given influenza virus in the lung is probably most readily impaired by antibodies to haemagglutinin rather than by T cells, including NP-specific cross-reactive T cells. This possibility is not necessarily in contradiction to the finding that cloned T cells may successfully protect recipients (Lin & Askonas, 1981 ; Luckacher et al., 1984) .
The present study cannot exclude a possible role of NP-specific CTL during recovery from a primary influenza virus infection. However, the passive transfer of NP-specific T cell clones might not reflect the entire reaction of the immune system during a natural infection or after immunization.
Since NP-expressing recombinant virus or a highly purified NP preparation could induce only relatively low levels of cross-reactive T cells the role of NP-specific CTL for recovery from an influenza virus infection cannot truly be evaluated.
